Expert team delivering innovative solutions

Creating solutions for rapid market analysis

In the realm of clinical diagnostics market access, there’s a noticeable scarcity of accessible data. Payor datasets tailored for the diagnostics industry are in short supply and often come with a hefty price tag. Moreover, they tend to be unstructured, making them labor and resource-intensive for end-users. Often the timeframe to do analyses and develop insights, in practical terms, precludes the use of data vendor solutions.

Our approach

At MA360i, we are committed to delivering innovative solutions that provide our clients with essential market access insights for their current and future portfolio. Our approach involves automation using smart-tags, proprietary algorithms, and AI- powered sentiment analysis, and transforming massive, messy datasets into insights.

Our mission at MA360i is to demystify the intricate and frequently overlooked landscape of market access for diagnostics. We offer user-friendly, rapid, and interactive dashboards equipped with advanced filters, enabling you to:

  • Analyze and annotate top tier diagnostics data, extracting crucial market access insights from payor data
  • Access and evaluate payor coverage policies for clinical diagnostics through our proprietary algorithms and AI language models.
  • Derive insights into payor reimbursement rates in a fast, user friendly platform enriched by connections and smart tags for top tier diagnostics.

Experienced Leadership

Our leadership team boasts decades of experience in market access strategy and market intelligence, ensuring that our clients receive expert guidance and support.

Rick Nida

Rick, the CEO and co-founder of NGS Reimbursement Solutions, brings over two decades of experience in the commercial healthcare and life sciences industry. In 2019, he established NGS Reimbursement Solutions, following a career spanning 18+ years in molecular diagnostic startups and consulting roles at renowned companies such as CareDx, Novartis Dx, Verinata Health, and Illumina.

With a solid 18-year foundation in molecular diagnostics and 10+ years in next-generation sequencing (NGS) based diagnostics, Rick’s leadership at Illumina, where he founded the Global Market Access team, was instrumental in resolving clients’ market access and reimbursement challenges in e.g., Oncology, Women’s Health, and Rare Undiagnosed Genetic Disease markets. Rick is an invited speaker at national meetings, addressing the ever-evolving landscape of molecular diagnostics, commercialization, coverage, evidence development, and reimbursement.

Aruna Rajan

Aruna has about two decades of experience helping companies in the healthcare sector make strategic decisions and accelerate ROI through guided assessments. She worked in the market insights group at Illumina leading market and competitive analyses to support senior executives, product marketing, investor relations and sales. Before Illumina, Aruna was a strategy consultant at Scientia Advisors, a boutique life science strategy consulting company.

Her expertise lies in providing strategic insights and actionable information to life science companies. Led problem solving efforts by identifying issues, forming hypotheses, designing, and conducting analyses, synthesizing conclusions into recommendations.

A different player in the market access space

We leverage our distinctive expertise in reimbursement, analytics, market intelligence, commercialization, and market access, tailored specifically for the diagnostics industry, to unravel critical information, data, and insights to power the industry forward. We’re not a data vendor – we are an information and insights provider. We work with you, by your side, as you plan and build on your business strategy and execution.